These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36114312)

  • 1. A general class of promotion time cure rate models with a new biological interpretation.
    Gómez YM; Gallardo DI; Bourguignon M; Bertolli E; Calsavara VF
    Lifetime Data Anal; 2023 Jan; 29(1):66-86. PubMed ID: 36114312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A flexible family of transformation cure rate models.
    Koutras MV; Milienos FS
    Stat Med; 2017 Jul; 36(16):2559-2575. PubMed ID: 28417477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On a class of non-linear transformation cure rate models.
    Balakrishnan N; Milienos FS
    Biom J; 2020 Sep; 62(5):1208-1222. PubMed ID: 32175632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term frailty modeling using a non-proportional hazards model: Application with a melanoma dataset.
    Calsavara VF; Milani EA; Bertolli E; Tomazella V
    Stat Methods Med Res; 2020 Aug; 29(8):2100-2118. PubMed ID: 31691640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportional hazards under Conway-Maxwell-Poisson cure rate model and associated inference.
    Balakrishnan N; Barui S; Milienos FS
    Stat Methods Med Res; 2017 Oct; 26(5):2055-2077. PubMed ID: 28523958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Bayesian destructive weighted Poisson cure rate model and an application to a cutaneous melanoma data.
    Rodrigues J; Cancho VG; de Castro M; Balakrishnan N
    Stat Methods Med Res; 2012 Dec; 21(6):585-97. PubMed ID: 21131689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectation maximization-based likelihood inference for flexible cure rate models with Weibull lifetimes.
    Balakrishnan N; Pal S
    Stat Methods Med Res; 2016 Aug; 25(4):1535-63. PubMed ID: 23740876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new cure rate model with flexible competing causes with applications to melanoma and transplantation data.
    Leão J; Bourguignon M; Gallardo DI; Rocha R; Tomazella V
    Stat Med; 2020 Oct; 39(24):3272-3284. PubMed ID: 32716081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the use of the modified power series family of distributions in a cure rate model context.
    Gallardo DI; Gómez YM; Gómez HW; de Castro M
    Stat Methods Med Res; 2020 Jul; 29(7):1831-1845. PubMed ID: 31559906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes.
    Pal S; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2093-2113. PubMed ID: 28656795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion time cure rate model with nonparametric form of covariate effects.
    Chen T; Du P
    Stat Med; 2018 May; 37(10):1625-1635. PubMed ID: 29341205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destructive weighted Poisson cure rate models.
    Rodrigues J; de Castro M; Balakrishnan N; Cancho VG
    Lifetime Data Anal; 2011 Jul; 17(3):333-46. PubMed ID: 21076872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxed Poisson cure rate models.
    Rodrigues J; Cordeiro GM; Cancho VG; Balakrishnan N
    Biom J; 2016 Mar; 58(2):397-415. PubMed ID: 26686485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighted Lindley frailty model: estimation and application to lung cancer data.
    Mota A; Milani EA; Calsavara VF; Tomazella VLD; Leão J; Ramos PL; Ferreira PH; Louzada F
    Lifetime Data Anal; 2021 Oct; 27(4):561-587. PubMed ID: 34331190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heteroscedastic transformation cure regression models.
    Chen CM; Chen CH
    Stat Med; 2016 Jun; 35(14):2359-76. PubMed ID: 26887342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On a reparameterization of a flexible family of cure models.
    Milienos FS
    Stat Med; 2022 Sep; 41(21):4091-4111. PubMed ID: 35716033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On a new piecewise regression model with cure rate: Diagnostics and application to medical data.
    Gómez YM; Gallardo DI; Leão J; Calsavara VF
    Stat Med; 2021 Dec; 40(29):6723-6742. PubMed ID: 34581460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transformation class for spatio-temporal survival data with a cure fraction.
    Hurtado Rúa SM; Dey DK
    Stat Methods Med Res; 2016 Feb; 25(1):167-87. PubMed ID: 22514030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling excess hazard with time-to-cure as a parameter.
    Boussari O; Bordes L; Romain G; Colonna M; Bossard N; Remontet L; Jooste V
    Biometrics; 2021 Dec; 77(4):1289-1302. PubMed ID: 32869288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.